Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment?
{{output}}
Recently, glucagon-like peptide-1 (GLP-1) receptor agonists have become a cornerstone for the treatment of obese patients with type 2 diabetes (T2D), exhibiting favorable effects on the cardiovascular outcome. In T2D, impaired GLP-1 secretion/function is obser... ...
